Diffuse malignant peritoneal mesothelioma: Evaluation of systemic chemotherapy with comprehensive treatment through the RENAPE Database: Multi-Institutional Retrospective Study
详细信息    查看全文
文摘

The combination of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) is the cornerstone of a curative treatment strategy for diffuse malignant peritoneal mesothelioma (DMPM).

All patients with a diagnostic of DMPM should be evaluated prior any treatment in an expert peritoneal surface malignancies (PSM) centre.

Upfront surgery appears preferable to neoadjuvant chemotherapy in patients amenable to complete CRS.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700